Alexia Iasonos | Algorithm Development | Best Researcher Award

Dr. Alexia Iasonos | Algorithm Development | Best Researcher Award

Memorial Sloan-Kettering Cancer Center | United States

Dr. Alexia E. Iasonos is a recognized expert in biostatistics, currently a Member at Memorial Sloan Kettering Cancer Center where she serves as Director of Clinical Research Development. She earned her B.S. in Mathematics & Statistics from the University of Cyprus (1992-96), followed by an M.S. in Biometry & Statistics and a Ph.D. in Biometry & Statistics from SUNY Albany (awarded in 1998 and 2002 respectively). Her professional trajectory includes roles in academic statistics, pharmaceutical industry, and extensive hospital-affiliated clinical trial biostatistics. Her methodological research focuses on design and analysis of clinical trials, especially Bayesian adaptive Phase I and II designs, dose-finding methods, dose-expansion cohort development, predictive modeling and nomograms, biomarker evaluation and endpoints, particularly in gynecologic oncology. Her work has been instrumental in improving early drug development processes. According to AD Scientific Index, her h-index is 52, with over 10,779 total citations. She is an elected Fellow of the Society of Clinical Trials, deputy editor of Journal of Clinical Oncology, member/chair in several protocol and monitoring committees. Among her awards are those tied to leadership in early-phase trial methodology and contributions to cancer biostatistics. In conclusion, Dr. Iasonos continues to make high impact contributions in biostatistics and oncology by combining rigorous methodology with translational collaboration.

Profile : Scopus

Featured Publications

Iasonos, A. (2024). Evaluation of early phase dose finding algorithms in heterogeneous populations. Journal of Statistical Planning and Inference.

Iasonos, A. (2023). Controlled amplification in oncology dose-finding trials. Contemporary Clinical Trials.

Iasonos, A. (2022). Stopping rules for phase I clinical trials with dose expansion cohorts. Statistical Methods in Medical Research.

Iasonos, A. (2021). Controlled backfill in oncology dose-finding trials. Contemporary Clinical Trials.

Iasonos, A. (2021). Phase I clinical trials in adoptive T-cell therapies. Journal of the Royal Statistical Society: Series C (Applied Statistics).

Zbigniew Pędzich | Best Researcher Award | statistical methods

Zbigniew Pędzich | Best Researcher Award - Award Winner 2023

Prof Zbigniew Pędzich : statistical methods

Congratulations to Prof. Zbigniew Pędzich for receiving the prestigious Best Researcher Award at the International Research Data Analysis Excellence Awards! Prof. Pędzich's exceptional work in statistical methods has not only earned him this esteemed recognition but also highlights his commitment to advancing research and data analysis in the international academic community. His innovative contributions have undoubtedly left a lasting impact on the field, showcasing excellence in research data analysis. Well-deserved accolades for a distinguished researcher!

Professional Profiles:

Early Academic Pursuits:

Zbigniew Pędzich was born in Krakow in 1963 and began his academic journey at the AGH University of Science and Technology. He pursued studies at the Faculty of Electronic, Automatic and Electrotechnic from 1982 to 1985. Subsequently, he continued his education at the Faculty of Materials Science and Ceramics, earning his M.Sc. in 1989.

Professional Endeavors:

Since 1995, Pędzich has been an integral part of AGH University, initially as an assistant and later as an assistant professor. His commitment to advancing knowledge in his field led him to achieve a Ph.D. in 1996, focusing on "Particulate composites in the system: tetragonal zirconia polycrystals – tungsten carbide," which earned him distinction. Over the years, he steadily progressed in his academic career, culminating in the title of Titular Professor in March 2020.

Contributions and Research Focus:

Zbigniew Pędzich has made significant contributions to the field of materials science and ceramics. His research has primarily centered on ceramic matrix composites for structural applications, refractories, and ceramifiable composites with polymer matrices. His Ph.D. thesis reflects his early dedication to advancing knowledge in the synthesis and properties of particulate composites.

Throughout his academic career, Pędzich has authored more than 200 publications, with 120 indexed on the Journal Citation Reports (JCR) list. Additionally, he holds over 20 patents related to the manufacturing and properties of structural ceramic materials and composites.

Accolades and Recognition:

Pędzich's outstanding contributions to the field have earned him numerous accolades and recognition. In 2013, he was honored as an ECerS Fellow by the European Ceramic Society (ECerS), highlighting his exemplary contributions to the ceramic community. In 2016, the Polish Ministry for Science and Higher Education awarded him the Medal of the National Commission for Education.

His dedication to the advancement of ceramics is further underscored by his role as the President of the Polish Ceramic Society since 2009. Additionally, he serves as a Polish Officer in the Council of the International Ceramic Federation (ICF) and is a member of the Permanent Executive Committee of the European Ceramic Society (ECerS) Council.

Impact and Influence:

Zbigniew Pędzich's influence extends beyond national borders, as evidenced by his involvement in international ceramic organizations. His leadership roles in ECerS and ICF demonstrate his commitment to fostering collaboration and advancing the field globally.

Legacy and Future Contributions:

As an Academician of the World Academy of Ceramic since 2023, Pędzich's legacy is firmly established in the global ceramics community. Looking ahead, his role as the Head of the Scientific Discipline of Chemical Engineering and the Department of Ceramics and Refractory Materials at AGH University positions him to continue shaping the future of materials science and ceramics. His ongoing research endeavors and leadership roles suggest a sustained commitment to advancing knowledge and fostering innovation in the field.